chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 0.5
Sex: M
Vaccine: HIBV
Symptoms: Device connection issue, Exposure via skin contact, Product complaint
Clinical narrative: Product Complaint; needle and hub detached; product spilled out on the patient's leg; product spilled out on the patient's leg; This non-serious case was reported by a other health professional via call center representative and described the occurrence of syringe connection issue in a 6-month-old male patient who received Hib (Hiberix) (batch number Y24T9, expiry date 14-MAR-2026) for prophylaxis. This case was associated with a product complaint.   On 27-JUN-2024, the patient received Hiberix (intramuscular). On 27-JUN-2024, an unknown time after receiving Hiberix, the patient experienced syringe connection issue (Verbatim: needle and hub detached), exposure via skin contact (Verbatim: product spilled out on the patient's leg) and inadvertent exposure to vaccine (Verbatim: product spilled out on the patient's leg). On an unknown date, the patient experienced pharmaceutical product complaint (Verbatim: Product Complaint). The outcome of the syringe connection issue, exposure via skin contact, inadvertent exposure to vaccine and pharmaceutical product complaint were unknown.   It was unknown if the reporter considered the syringe connection issue to be related to Hiberix and Hiberix And Diluent Pre-Filled Syringe Device.     It was unknown if the company considered the syringe connection issue to be related to Hiberix and Hiberix And Diluent Pre-Filled Syringe Device.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 26-JUN-2024 It was reported that vaccine spilled onto patient's leg. The Healthcare professional reported that they experienced the needle coming loose during administration of HIBERIX. After sticking the patient, the needle detached and the product spilled out on the patient's leg and on the table. The suspect product had been discarded, so was not available for return. The report was originally called in by the Office Manager, but the clinical information was received from the Medical Assistant, so that was the name in the case which led to syringe connection issue, exposure via skin contact, inadvertent exposure to vaccine and pharmaceutical product complaint. It was confirmed that that all operations were performed appropriately before defect was discovered. The defect was discovered while attaching 2nd needle, thought the needle/syringe would be stable to inject. The vaccine was not administered, spilled out on baby's leg. Saline syringe clearly describe which components was involved in the complaint. While unscrewing rigid cap, the syringe was held securely by the barrel while attempting to unscrew the cap. The cap was pulled off or unscrewed by twisting it counterclockwise as directed in the product instructions. Mckesson 5/8 25g not safety needle was used. The needle was aligned, screwed on gently, the luer lock spun at this time. The needle and hub detached, all product spilled out.
Age: 76.0
Sex: M
Vaccine: VARZOS
Symptoms: Inappropriate schedule of product administration
Clinical narrative: late 2nd dose2; This non-serious case was reported by a consumer via call center representative and described the occurrence of drug dose administration interval too long in a 76-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingles vaccine (received 1st dose many years ago).   On 27-JUN-2024, the patient received the 2nd dose of Shingrix. On 27-JUN-2024, an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too long (Verbatim: late 2nd dose2). The outcome of the drug dose administration interval too long was unknown.   Additional Information: GSK Receipt Date: 27-JUN-2024 The reporter stated that he had multiple doses of the shingles vaccine (unknown manufacturer). He did not know if he received more than 2.  He received one dose many years ago, and stated he got another 2 doses on day of reporting. The patient received 2nd dose of Shingrix, later than the recommended interval, which led to lengthening of vaccinations schedule.
Sex: U
Vaccine: VARZOS
Symptoms: Product preparation issue
Clinical narrative: administered only diluent part; administered only diluent part; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: administered only diluent part) and inappropriate dose of vaccine administered (Verbatim: administered only diluent part). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt Date: 27-JUN-2024 A nurse administered only the  diluent part of the  Shingrix, without mixing with the tablet or the powder and they give only the diluent part which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Blister
Clinical narrative: Legs are breaking out with blisters, little white pimples on it, burn and itch like hell, oozes, it's very red, it's below the knee and the top of the foot; This spontaneous case was reported by a patient and describes the occurrence of BLISTER (Legs are breaking out with blisters, little white pimples on it, burn and itch like hell, oozes, it's very red, it's below the knee and the top of the foot) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025821A, 009C21A and 078J21A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Jan-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, the patient experienced BLISTER (Legs are breaking out with blisters, little white pimples on it, burn and itch like hell, oozes, it's very red, it's below the knee and the top of the foot). At the time of the report, BLISTER (Legs are breaking out with blisters, little white pimples on it, burn and itch like hell, oozes, it's very red, it's below the knee and the top of the foot) had not resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.  Patient never had nothing like this in life even as a kid playing in poison ivy. It's been going for a couple years. Patient stated big thing was it looked like measles. They were horrifying, in fact they have busted out. Patient was trying to keep a solution on it, but it oozed out.   This case was linked to US-MODERNATX, INC.-MOD-2024-770512 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2024-770512:Vet's Father case
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, COVID-19, SARS-CoV-2 test
Clinical narrative: COVID-19 infection/antigen test. He tested positive on the 27th; This spontaneous case was reported by a patient family member or friend and describes the occurrence of COVID-19 (COVID-19 infection/antigen test. He tested positive on the 27th) in a male patient of an unknown age who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis.     No Medical History information was reported.  On an unknown date, the patient received seventh dose of SPIKEVAX NOS (SPIKEVAX NOS) (unknown route) 1 dosage form. On 25-Jun-2024, the patient experienced COVID-19 (COVID-19 infection/antigen test. He tested positive on the 27th). At the time of the report, COVID-19 (COVID-19 infection/antigen test. He tested positive on the 27th) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In June 2024, Body temperature: 100.4 and 99 or below. On 27-Jun-2024, SARS-CoV-2 test: (Positive) He tested positive on the 27th.  For SPIKEVAX NOS (SPIKEVAX NOS) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Unknown if patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.  Patient started to feel better. Reporter reported the exposure was on 22-Jun-2024. Her husband developed symptoms on the 25-Jun-2024. The reporter stated that her husband had the same number as she did, but he went to different locations. Symptoms throughout the whole course were upper respiratory symptoms, runny nose cough, muscle aches and temperature of 100.4. The 100.4 was on the day he tested positive. So that would have been on the 27-Jun-2024 and then thereafter it was 99 or below. The cough continued bad. On 28-Jun-2024, his cough was better as the reporter. They feel like they were over the hump on the mend and did not get packs of it. As per reporter symptoms were resolving. He was feeling better. He was feeling so, he sleeps forever with this thing. He had a sore throat also. The reporter also added that early during COVID, they were part of a study at the Institute and monthly they would send in blood and saliva samples. The reporter thought they did it for about six months. This was before vaccines were available. Reporter stated and thought that this might be a different variant. She was thinking why with a minimal exposure did they get socked with this one.  Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2024-770514 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 01-Jul-2024: Live follow-up information received included significant information added lab details, event onset date and updated narrative. On 02-Jul-2024: Live follow-up information received included non-significant information added reference numbers in reference section.; Sender's Comments:  US-MODERNATX, INC.-MOD-2024-770514:Wife case
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cold sweat, Headache, Insomnia, Pain
Clinical narrative: inability to sleep; he most disturbing was right ear tinnitus/I awoke to hearing a helicopter landing on our house; total body aches; an overnight of chills sweats; an overnight of chills sweats; headaches; This spontaneous case was reported by a patient and describes the occurrence of INSOMNIA (inability to sleep), TINNITUS (he most disturbing was right ear tinnitus/I awoke to hearing a helicopter landing on our house), PAIN (total body aches), COLD SWEAT (an overnight of chills sweats) and CHILLS (an overnight of chills sweats) in a 71-year-old female patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 30-Jun-2024, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (Intramuscular use) 1 dosage form. On 30-Jun-2024, the patient experienced INSOMNIA (inability to sleep), TINNITUS (he most disturbing was right ear tinnitus/I awoke to hearing a helicopter landing on our house), PAIN (total body aches), COLD SWEAT (an overnight of chills sweats), CHILLS (an overnight of chills sweats) and HEADACHE (headaches). At the time of the report, INSOMNIA (inability to sleep), TINNITUS (he most disturbing was right ear tinnitus/I awoke to hearing a helicopter landing on our house), PAIN (total body aches), COLD SWEAT (an overnight of chills sweats), CHILLS (an overnight of chills sweats) and HEADACHE (headaches) was resolving.        For mRNA-1273.815 (SPIKEVAX 2023-2024) (Intramuscular use), the reporter did not provide any causality assessments.   No concomitant medications were reported.  The patient reported that, the most disturbing was right ear tinnitus- after an overnight of chills sweats, headaches, total body aches and inability to sleep. She awoke to hearing a helicopter landing on her house and was able to get out of bed to look for source, when her husband came out and said he did not hear it. She plugged her ear, and she was going to estimate length as under 20 minutes. It was unknown if the patient experienced any additional symptoms/events.  No treatment information was provided.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: inability to sleep; he most disturbing was right ear tinnitus/I awoke to hearing a helicopter landing on our house; total body aches; an overnight of chills sweats; an overnight of chills sweats; headaches; This spontaneous case was reported by a patient and describes the occurrence of INSOMNIA (inability to sleep), TINNITUS (he most disturbing was right ear tinnitus/I awoke to hearing a helicopter landing on our house), PAIN (total body aches), COLD SWEAT (an overnight of chills sweats) and CHILLS (an overnight of chills sweats) in a 71-year-old female patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 30-Jun-2024, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (Intramuscular use) 1 dosage form. On 30-Jun-2024, the patient experienced INSOMNIA (inability to sleep), TINNITUS (he most disturbing was right ear tinnitus/I awoke to hearing a helicopter landing on our house), PAIN (total body aches), COLD SWEAT (an overnight of chills sweats), CHILLS (an overnight of chills sweats) and HEADACHE (headaches). At the time of the report, INSOMNIA (inability to sleep), TINNITUS (he most disturbing was right ear tinnitus/I awoke to hearing a helicopter landing on our house), PAIN (total body aches), COLD SWEAT (an overnight of chills sweats), CHILLS (an overnight of chills sweats) and HEADACHE (headaches) was resolving.        For mRNA-1273.815 (SPIKEVAX 2023-2024) (Intramuscular use), the reporter did not provide any causality assessments.   No concomitant medications were reported.  The patient reported that, the most disturbing was right ear tinnitus- after an overnight of chills sweats, headaches, total body aches and inability to sleep. She awoke to hearing a helicopter landing on her house and was able to get out of bed to look for source, when her husband came out and said he did not hear it. She plugged her ear, and she was going to estimate length as under 20 minutes. It was unknown if the patient experienced any additional symptoms/events.  No treatment information was provided.
Age: 35.0
Sex: M
Vaccine: TDAP
Symptoms: Angioedema, Lip swelling, Swelling face
Clinical narrative: onset of left sided facial swelling and left sided lip swelling on 7/3, progressed on 7/4. Did not respond to 25 mg diphendryamine at home. Thought to be angioedema based on exam and history.  Given 40 mg prednisone and 50 mg diphenhydramine in clinic.
Age: 55.0
Sex: F
Vaccine: VARZOS
Symptoms: Fatigue, Pyrexia
Clinical narrative: Fever of 100.4 F, fatigue. Fever started around 8 pm and rose during the night. Back to normal by mid morning with fatigue still lingering
Age: 22.0
Sex: M
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site pruritus, Injection site rash, Injection site swelling
Clinical narrative: Large Red Swollen Patch at site of injection. Patient describes it as itchy but not painful. Pt reported to medical and was given ICE and 600mg ibuprofen at 1345 on July 4th, 2024. Skin marker was used to trace the outline of the rash to track growth. The rash measured at 13 X 8 CM.
Age: 50.0
Sex: M
Vaccine: PNC20, VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: right arm swelling tenderness redness and heat spreading from the deltoid down towards the elbow
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Amino acid level abnormal, Anxiety, Aphasia, Arthralgia, Back pain
Clinical narrative: the next day I experienced atypical, excessive , and painful menstrual bleeding that remained constant for several months. I did not have consistent cycles without breakthrough bleeding, even though I was prescribed birth control to remedy. I was later diagnosed with subserosal leiomyoma/leiomyoma of uterus in 2022.  In 2023, the following symptoms began and I was diagnosed with Mast Cell Activation Syndrome in 2023: dizziness/vertigo, insomnia, headaches, chronic fatigue, changes to taste and smell, joint and muscle pain, anxiety, mood changes, eye-blurriness, cognition-impairment, chest pain/palpitations, anxiety, inflammation, facial and chest flushing, nerve pain and burning, loss of sensation in extremities, histamine intolerance, hypotension. I received multiple scans to identify the cause of all of my symptoms and rule out other conditions that could cause them. An MRI of my pelvic area showed a bulky uterus. After experiencing a worsening of the menstrual bleeding and lower back pain and pressure on my bladder over this same time period, my Gynecologist shared that the most permanent and effective remedy for my issues was to have a hysterectomy.  I had the hysterectomy on 2/27/24. The treatment for Mast Cell Activation Syndrome consists of increased anti-histamines, a mast cell stabilizer, and a low-histamine diet, which I was prescribed and benefited to some degree from being on. I sought treatment for my lingering fatigue and cognition impairments after my hysterectomy, at a Wellness Center, where I received a variety of treatments including, hyperbaric oxygen therapy, IV therapy, hormone replacement therapy, treatment with steroids, low dose naltexrone, and a significant amount of supplements and nutritional support. Since this treatment program, I have returned to work and am performing normal duties with this elevated level of prescription and nutritional support. My fatigue is improved, although I tire more easily and require more sleep. My impaired cognition has also improved, but I still experience word-finding issues, brain-fog, lack of concentration, all worsened by energy exertion.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Brain fog, Burning sensation, Cardiac monitoring, Cardiac murmur
Clinical narrative: the next day I experienced atypical, excessive , and painful menstrual bleeding that remained constant for several months. I did not have consistent cycles without breakthrough bleeding, even though I was prescribed birth control to remedy. I was later diagnosed with subserosal leiomyoma/leiomyoma of uterus in 2022.  In 2023, the following symptoms began and I was diagnosed with Mast Cell Activation Syndrome in 2023: dizziness/vertigo, insomnia, headaches, chronic fatigue, changes to taste and smell, joint and muscle pain, anxiety, mood changes, eye-blurriness, cognition-impairment, chest pain/palpitations, anxiety, inflammation, facial and chest flushing, nerve pain and burning, loss of sensation in extremities, histamine intolerance, hypotension. I received multiple scans to identify the cause of all of my symptoms and rule out other conditions that could cause them. An MRI of my pelvic area showed a bulky uterus. After experiencing a worsening of the menstrual bleeding and lower back pain and pressure on my bladder over this same time period, my Gynecologist shared that the most permanent and effective remedy for my issues was to have a hysterectomy.  I had the hysterectomy on 2/27/24. The treatment for Mast Cell Activation Syndrome consists of increased anti-histamines, a mast cell stabilizer, and a low-histamine diet, which I was prescribed and benefited to some degree from being on. I sought treatment for my lingering fatigue and cognition impairments after my hysterectomy, at a Wellness Center, where I received a variety of treatments including, hyperbaric oxygen therapy, IV therapy, hormone replacement therapy, treatment with steroids, low dose naltexrone, and a significant amount of supplements and nutritional support. Since this treatment program, I have returned to work and am performing normal duties with this elevated level of prescription and nutritional support. My fatigue is improved, although I tire more easily and require more sleep. My impaired cognition has also improved, but I still experience word-finding issues, brain-fog, lack of concentration, all worsened by energy exertion.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cardiac stress test, Cardiovascular evaluation, Chest pain, Cognitive disorder, Computerised tomogram abdomen abnormal
Clinical narrative: the next day I experienced atypical, excessive , and painful menstrual bleeding that remained constant for several months. I did not have consistent cycles without breakthrough bleeding, even though I was prescribed birth control to remedy. I was later diagnosed with subserosal leiomyoma/leiomyoma of uterus in 2022.  In 2023, the following symptoms began and I was diagnosed with Mast Cell Activation Syndrome in 2023: dizziness/vertigo, insomnia, headaches, chronic fatigue, changes to taste and smell, joint and muscle pain, anxiety, mood changes, eye-blurriness, cognition-impairment, chest pain/palpitations, anxiety, inflammation, facial and chest flushing, nerve pain and burning, loss of sensation in extremities, histamine intolerance, hypotension. I received multiple scans to identify the cause of all of my symptoms and rule out other conditions that could cause them. An MRI of my pelvic area showed a bulky uterus. After experiencing a worsening of the menstrual bleeding and lower back pain and pressure on my bladder over this same time period, my Gynecologist shared that the most permanent and effective remedy for my issues was to have a hysterectomy.  I had the hysterectomy on 2/27/24. The treatment for Mast Cell Activation Syndrome consists of increased anti-histamines, a mast cell stabilizer, and a low-histamine diet, which I was prescribed and benefited to some degree from being on. I sought treatment for my lingering fatigue and cognition impairments after my hysterectomy, at a Wellness Center, where I received a variety of treatments including, hyperbaric oxygen therapy, IV therapy, hormone replacement therapy, treatment with steroids, low dose naltexrone, and a significant amount of supplements and nutritional support. Since this treatment program, I have returned to work and am performing normal duties with this elevated level of prescription and nutritional support. My fatigue is improved, although I tire more easily and require more sleep. My impaired cognition has also improved, but I still experience word-finding issues, brain-fog, lack of concentration, all worsened by energy exertion.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram heart, Computerised tomogram thorax, Contraception, Cortisol abnormal, Cysteine urine
Clinical narrative: the next day I experienced atypical, excessive , and painful menstrual bleeding that remained constant for several months. I did not have consistent cycles without breakthrough bleeding, even though I was prescribed birth control to remedy. I was later diagnosed with subserosal leiomyoma/leiomyoma of uterus in 2022.  In 2023, the following symptoms began and I was diagnosed with Mast Cell Activation Syndrome in 2023: dizziness/vertigo, insomnia, headaches, chronic fatigue, changes to taste and smell, joint and muscle pain, anxiety, mood changes, eye-blurriness, cognition-impairment, chest pain/palpitations, anxiety, inflammation, facial and chest flushing, nerve pain and burning, loss of sensation in extremities, histamine intolerance, hypotension. I received multiple scans to identify the cause of all of my symptoms and rule out other conditions that could cause them. An MRI of my pelvic area showed a bulky uterus. After experiencing a worsening of the menstrual bleeding and lower back pain and pressure on my bladder over this same time period, my Gynecologist shared that the most permanent and effective remedy for my issues was to have a hysterectomy.  I had the hysterectomy on 2/27/24. The treatment for Mast Cell Activation Syndrome consists of increased anti-histamines, a mast cell stabilizer, and a low-histamine diet, which I was prescribed and benefited to some degree from being on. I sought treatment for my lingering fatigue and cognition impairments after my hysterectomy, at a Wellness Center, where I received a variety of treatments including, hyperbaric oxygen therapy, IV therapy, hormone replacement therapy, treatment with steroids, low dose naltexrone, and a significant amount of supplements and nutritional support. Since this treatment program, I have returned to work and am performing normal duties with this elevated level of prescription and nutritional support. My fatigue is improved, although I tire more easily and require more sleep. My impaired cognition has also improved, but I still experience word-finding issues, brain-fog, lack of concentration, all worsened by energy exertion.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cytogenetic analysis abnormal, Discomfort, Disturbance in attention, Dizziness, Dysmenorrhoea
Clinical narrative: the next day I experienced atypical, excessive , and painful menstrual bleeding that remained constant for several months. I did not have consistent cycles without breakthrough bleeding, even though I was prescribed birth control to remedy. I was later diagnosed with subserosal leiomyoma/leiomyoma of uterus in 2022.  In 2023, the following symptoms began and I was diagnosed with Mast Cell Activation Syndrome in 2023: dizziness/vertigo, insomnia, headaches, chronic fatigue, changes to taste and smell, joint and muscle pain, anxiety, mood changes, eye-blurriness, cognition-impairment, chest pain/palpitations, anxiety, inflammation, facial and chest flushing, nerve pain and burning, loss of sensation in extremities, histamine intolerance, hypotension. I received multiple scans to identify the cause of all of my symptoms and rule out other conditions that could cause them. An MRI of my pelvic area showed a bulky uterus. After experiencing a worsening of the menstrual bleeding and lower back pain and pressure on my bladder over this same time period, my Gynecologist shared that the most permanent and effective remedy for my issues was to have a hysterectomy.  I had the hysterectomy on 2/27/24. The treatment for Mast Cell Activation Syndrome consists of increased anti-histamines, a mast cell stabilizer, and a low-histamine diet, which I was prescribed and benefited to some degree from being on. I sought treatment for my lingering fatigue and cognition impairments after my hysterectomy, at a Wellness Center, where I received a variety of treatments including, hyperbaric oxygen therapy, IV therapy, hormone replacement therapy, treatment with steroids, low dose naltexrone, and a significant amount of supplements and nutritional support. Since this treatment program, I have returned to work and am performing normal duties with this elevated level of prescription and nutritional support. My fatigue is improved, although I tire more easily and require more sleep. My impaired cognition has also improved, but I still experience word-finding issues, brain-fog, lack of concentration, all worsened by energy exertion.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Early repolarisation syndrome, Echocardiogram, Fatigue, Flushing, Glutathione decreased
Clinical narrative: the next day I experienced atypical, excessive , and painful menstrual bleeding that remained constant for several months. I did not have consistent cycles without breakthrough bleeding, even though I was prescribed birth control to remedy. I was later diagnosed with subserosal leiomyoma/leiomyoma of uterus in 2022.  In 2023, the following symptoms began and I was diagnosed with Mast Cell Activation Syndrome in 2023: dizziness/vertigo, insomnia, headaches, chronic fatigue, changes to taste and smell, joint and muscle pain, anxiety, mood changes, eye-blurriness, cognition-impairment, chest pain/palpitations, anxiety, inflammation, facial and chest flushing, nerve pain and burning, loss of sensation in extremities, histamine intolerance, hypotension. I received multiple scans to identify the cause of all of my symptoms and rule out other conditions that could cause them. An MRI of my pelvic area showed a bulky uterus. After experiencing a worsening of the menstrual bleeding and lower back pain and pressure on my bladder over this same time period, my Gynecologist shared that the most permanent and effective remedy for my issues was to have a hysterectomy.  I had the hysterectomy on 2/27/24. The treatment for Mast Cell Activation Syndrome consists of increased anti-histamines, a mast cell stabilizer, and a low-histamine diet, which I was prescribed and benefited to some degree from being on. I sought treatment for my lingering fatigue and cognition impairments after my hysterectomy, at a Wellness Center, where I received a variety of treatments including, hyperbaric oxygen therapy, IV therapy, hormone replacement therapy, treatment with steroids, low dose naltexrone, and a significant amount of supplements and nutritional support. Since this treatment program, I have returned to work and am performing normal duties with this elevated level of prescription and nutritional support. My fatigue is improved, although I tire more easily and require more sleep. My impaired cognition has also improved, but I still experience word-finding issues, brain-fog, lack of concentration, all worsened by energy exertion.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Glutathione test, Headache, Heart valve incompetence, Heavy menstrual bleeding, Histamine intolerance
Clinical narrative: the next day I experienced atypical, excessive , and painful menstrual bleeding that remained constant for several months. I did not have consistent cycles without breakthrough bleeding, even though I was prescribed birth control to remedy. I was later diagnosed with subserosal leiomyoma/leiomyoma of uterus in 2022.  In 2023, the following symptoms began and I was diagnosed with Mast Cell Activation Syndrome in 2023: dizziness/vertigo, insomnia, headaches, chronic fatigue, changes to taste and smell, joint and muscle pain, anxiety, mood changes, eye-blurriness, cognition-impairment, chest pain/palpitations, anxiety, inflammation, facial and chest flushing, nerve pain and burning, loss of sensation in extremities, histamine intolerance, hypotension. I received multiple scans to identify the cause of all of my symptoms and rule out other conditions that could cause them. An MRI of my pelvic area showed a bulky uterus. After experiencing a worsening of the menstrual bleeding and lower back pain and pressure on my bladder over this same time period, my Gynecologist shared that the most permanent and effective remedy for my issues was to have a hysterectomy.  I had the hysterectomy on 2/27/24. The treatment for Mast Cell Activation Syndrome consists of increased anti-histamines, a mast cell stabilizer, and a low-histamine diet, which I was prescribed and benefited to some degree from being on. I sought treatment for my lingering fatigue and cognition impairments after my hysterectomy, at a Wellness Center, where I received a variety of treatments including, hyperbaric oxygen therapy, IV therapy, hormone replacement therapy, treatment with steroids, low dose naltexrone, and a significant amount of supplements and nutritional support. Since this treatment program, I have returned to work and am performing normal duties with this elevated level of prescription and nutritional support. My fatigue is improved, although I tire more easily and require more sleep. My impaired cognition has also improved, but I still experience word-finding issues, brain-fog, lack of concentration, all worsened by energy exertion.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hormone replacement therapy, Hypotension, Hysterectomy, Impaired work ability, Increased need for sleep
Clinical narrative: the next day I experienced atypical, excessive , and painful menstrual bleeding that remained constant for several months. I did not have consistent cycles without breakthrough bleeding, even though I was prescribed birth control to remedy. I was later diagnosed with subserosal leiomyoma/leiomyoma of uterus in 2022.  In 2023, the following symptoms began and I was diagnosed with Mast Cell Activation Syndrome in 2023: dizziness/vertigo, insomnia, headaches, chronic fatigue, changes to taste and smell, joint and muscle pain, anxiety, mood changes, eye-blurriness, cognition-impairment, chest pain/palpitations, anxiety, inflammation, facial and chest flushing, nerve pain and burning, loss of sensation in extremities, histamine intolerance, hypotension. I received multiple scans to identify the cause of all of my symptoms and rule out other conditions that could cause them. An MRI of my pelvic area showed a bulky uterus. After experiencing a worsening of the menstrual bleeding and lower back pain and pressure on my bladder over this same time period, my Gynecologist shared that the most permanent and effective remedy for my issues was to have a hysterectomy.  I had the hysterectomy on 2/27/24. The treatment for Mast Cell Activation Syndrome consists of increased anti-histamines, a mast cell stabilizer, and a low-histamine diet, which I was prescribed and benefited to some degree from being on. I sought treatment for my lingering fatigue and cognition impairments after my hysterectomy, at a Wellness Center, where I received a variety of treatments including, hyperbaric oxygen therapy, IV therapy, hormone replacement therapy, treatment with steroids, low dose naltexrone, and a significant amount of supplements and nutritional support. Since this treatment program, I have returned to work and am performing normal duties with this elevated level of prescription and nutritional support. My fatigue is improved, although I tire more easily and require more sleep. My impaired cognition has also improved, but I still experience word-finding issues, brain-fog, lack of concentration, all worsened by energy exertion.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Inflammation, Inflammatory marker test, Insomnia, Intermenstrual bleeding, Laboratory test abnormal
Clinical narrative: the next day I experienced atypical, excessive , and painful menstrual bleeding that remained constant for several months. I did not have consistent cycles without breakthrough bleeding, even though I was prescribed birth control to remedy. I was later diagnosed with subserosal leiomyoma/leiomyoma of uterus in 2022.  In 2023, the following symptoms began and I was diagnosed with Mast Cell Activation Syndrome in 2023: dizziness/vertigo, insomnia, headaches, chronic fatigue, changes to taste and smell, joint and muscle pain, anxiety, mood changes, eye-blurriness, cognition-impairment, chest pain/palpitations, anxiety, inflammation, facial and chest flushing, nerve pain and burning, loss of sensation in extremities, histamine intolerance, hypotension. I received multiple scans to identify the cause of all of my symptoms and rule out other conditions that could cause them. An MRI of my pelvic area showed a bulky uterus. After experiencing a worsening of the menstrual bleeding and lower back pain and pressure on my bladder over this same time period, my Gynecologist shared that the most permanent and effective remedy for my issues was to have a hysterectomy.  I had the hysterectomy on 2/27/24. The treatment for Mast Cell Activation Syndrome consists of increased anti-histamines, a mast cell stabilizer, and a low-histamine diet, which I was prescribed and benefited to some degree from being on. I sought treatment for my lingering fatigue and cognition impairments after my hysterectomy, at a Wellness Center, where I received a variety of treatments including, hyperbaric oxygen therapy, IV therapy, hormone replacement therapy, treatment with steroids, low dose naltexrone, and a significant amount of supplements and nutritional support. Since this treatment program, I have returned to work and am performing normal duties with this elevated level of prescription and nutritional support. My fatigue is improved, although I tire more easily and require more sleep. My impaired cognition has also improved, but I still experience word-finding issues, brain-fog, lack of concentration, all worsened by energy exertion.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Laboratory test normal, Loss of personal independence in daily activities, Magnetic resonance imaging head, Magnetic resonance imaging pelvic, Magnetic resonance imaging spinal
Clinical narrative: the next day I experienced atypical, excessive , and painful menstrual bleeding that remained constant for several months. I did not have consistent cycles without breakthrough bleeding, even though I was prescribed birth control to remedy. I was later diagnosed with subserosal leiomyoma/leiomyoma of uterus in 2022.  In 2023, the following symptoms began and I was diagnosed with Mast Cell Activation Syndrome in 2023: dizziness/vertigo, insomnia, headaches, chronic fatigue, changes to taste and smell, joint and muscle pain, anxiety, mood changes, eye-blurriness, cognition-impairment, chest pain/palpitations, anxiety, inflammation, facial and chest flushing, nerve pain and burning, loss of sensation in extremities, histamine intolerance, hypotension. I received multiple scans to identify the cause of all of my symptoms and rule out other conditions that could cause them. An MRI of my pelvic area showed a bulky uterus. After experiencing a worsening of the menstrual bleeding and lower back pain and pressure on my bladder over this same time period, my Gynecologist shared that the most permanent and effective remedy for my issues was to have a hysterectomy.  I had the hysterectomy on 2/27/24. The treatment for Mast Cell Activation Syndrome consists of increased anti-histamines, a mast cell stabilizer, and a low-histamine diet, which I was prescribed and benefited to some degree from being on. I sought treatment for my lingering fatigue and cognition impairments after my hysterectomy, at a Wellness Center, where I received a variety of treatments including, hyperbaric oxygen therapy, IV therapy, hormone replacement therapy, treatment with steroids, low dose naltexrone, and a significant amount of supplements and nutritional support. Since this treatment program, I have returned to work and am performing normal duties with this elevated level of prescription and nutritional support. My fatigue is improved, although I tire more easily and require more sleep. My impaired cognition has also improved, but I still experience word-finding issues, brain-fog, lack of concentration, all worsened by energy exertion.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Mast cell activation syndrome, Menstrual disorder, Menstruation irregular, Mood altered, Myalgia
Clinical narrative: the next day I experienced atypical, excessive , and painful menstrual bleeding that remained constant for several months. I did not have consistent cycles without breakthrough bleeding, even though I was prescribed birth control to remedy. I was later diagnosed with subserosal leiomyoma/leiomyoma of uterus in 2022.  In 2023, the following symptoms began and I was diagnosed with Mast Cell Activation Syndrome in 2023: dizziness/vertigo, insomnia, headaches, chronic fatigue, changes to taste and smell, joint and muscle pain, anxiety, mood changes, eye-blurriness, cognition-impairment, chest pain/palpitations, anxiety, inflammation, facial and chest flushing, nerve pain and burning, loss of sensation in extremities, histamine intolerance, hypotension. I received multiple scans to identify the cause of all of my symptoms and rule out other conditions that could cause them. An MRI of my pelvic area showed a bulky uterus. After experiencing a worsening of the menstrual bleeding and lower back pain and pressure on my bladder over this same time period, my Gynecologist shared that the most permanent and effective remedy for my issues was to have a hysterectomy.  I had the hysterectomy on 2/27/24. The treatment for Mast Cell Activation Syndrome consists of increased anti-histamines, a mast cell stabilizer, and a low-histamine diet, which I was prescribed and benefited to some degree from being on. I sought treatment for my lingering fatigue and cognition impairments after my hysterectomy, at a Wellness Center, where I received a variety of treatments including, hyperbaric oxygen therapy, IV therapy, hormone replacement therapy, treatment with steroids, low dose naltexrone, and a significant amount of supplements and nutritional support. Since this treatment program, I have returned to work and am performing normal duties with this elevated level of prescription and nutritional support. My fatigue is improved, although I tire more easily and require more sleep. My impaired cognition has also improved, but I still experience word-finding issues, brain-fog, lack of concentration, all worsened by energy exertion.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Neuralgia, Palpitations, Parosmia, Scan, Sensory loss
Clinical narrative: the next day I experienced atypical, excessive , and painful menstrual bleeding that remained constant for several months. I did not have consistent cycles without breakthrough bleeding, even though I was prescribed birth control to remedy. I was later diagnosed with subserosal leiomyoma/leiomyoma of uterus in 2022.  In 2023, the following symptoms began and I was diagnosed with Mast Cell Activation Syndrome in 2023: dizziness/vertigo, insomnia, headaches, chronic fatigue, changes to taste and smell, joint and muscle pain, anxiety, mood changes, eye-blurriness, cognition-impairment, chest pain/palpitations, anxiety, inflammation, facial and chest flushing, nerve pain and burning, loss of sensation in extremities, histamine intolerance, hypotension. I received multiple scans to identify the cause of all of my symptoms and rule out other conditions that could cause them. An MRI of my pelvic area showed a bulky uterus. After experiencing a worsening of the menstrual bleeding and lower back pain and pressure on my bladder over this same time period, my Gynecologist shared that the most permanent and effective remedy for my issues was to have a hysterectomy.  I had the hysterectomy on 2/27/24. The treatment for Mast Cell Activation Syndrome consists of increased anti-histamines, a mast cell stabilizer, and a low-histamine diet, which I was prescribed and benefited to some degree from being on. I sought treatment for my lingering fatigue and cognition impairments after my hysterectomy, at a Wellness Center, where I received a variety of treatments including, hyperbaric oxygen therapy, IV therapy, hormone replacement therapy, treatment with steroids, low dose naltexrone, and a significant amount of supplements and nutritional support. Since this treatment program, I have returned to work and am performing normal duties with this elevated level of prescription and nutritional support. My fatigue is improved, although I tire more easily and require more sleep. My impaired cognition has also improved, but I still experience word-finding issues, brain-fog, lack of concentration, all worsened by energy exertion.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Stool analysis, Taste disorder, Toxicologic test abnormal, Urine analysis, Uterine enlargement
Clinical narrative: the next day I experienced atypical, excessive , and painful menstrual bleeding that remained constant for several months. I did not have consistent cycles without breakthrough bleeding, even though I was prescribed birth control to remedy. I was later diagnosed with subserosal leiomyoma/leiomyoma of uterus in 2022.  In 2023, the following symptoms began and I was diagnosed with Mast Cell Activation Syndrome in 2023: dizziness/vertigo, insomnia, headaches, chronic fatigue, changes to taste and smell, joint and muscle pain, anxiety, mood changes, eye-blurriness, cognition-impairment, chest pain/palpitations, anxiety, inflammation, facial and chest flushing, nerve pain and burning, loss of sensation in extremities, histamine intolerance, hypotension. I received multiple scans to identify the cause of all of my symptoms and rule out other conditions that could cause them. An MRI of my pelvic area showed a bulky uterus. After experiencing a worsening of the menstrual bleeding and lower back pain and pressure on my bladder over this same time period, my Gynecologist shared that the most permanent and effective remedy for my issues was to have a hysterectomy.  I had the hysterectomy on 2/27/24. The treatment for Mast Cell Activation Syndrome consists of increased anti-histamines, a mast cell stabilizer, and a low-histamine diet, which I was prescribed and benefited to some degree from being on. I sought treatment for my lingering fatigue and cognition impairments after my hysterectomy, at a Wellness Center, where I received a variety of treatments including, hyperbaric oxygen therapy, IV therapy, hormone replacement therapy, treatment with steroids, low dose naltexrone, and a significant amount of supplements and nutritional support. Since this treatment program, I have returned to work and am performing normal duties with this elevated level of prescription and nutritional support. My fatigue is improved, although I tire more easily and require more sleep. My impaired cognition has also improved, but I still experience word-finding issues, brain-fog, lack of concentration, all worsened by energy exertion.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Uterine leiomyoma, Vertigo, Vision blurred
Clinical narrative: the next day I experienced atypical, excessive , and painful menstrual bleeding that remained constant for several months. I did not have consistent cycles without breakthrough bleeding, even though I was prescribed birth control to remedy. I was later diagnosed with subserosal leiomyoma/leiomyoma of uterus in 2022.  In 2023, the following symptoms began and I was diagnosed with Mast Cell Activation Syndrome in 2023: dizziness/vertigo, insomnia, headaches, chronic fatigue, changes to taste and smell, joint and muscle pain, anxiety, mood changes, eye-blurriness, cognition-impairment, chest pain/palpitations, anxiety, inflammation, facial and chest flushing, nerve pain and burning, loss of sensation in extremities, histamine intolerance, hypotension. I received multiple scans to identify the cause of all of my symptoms and rule out other conditions that could cause them. An MRI of my pelvic area showed a bulky uterus. After experiencing a worsening of the menstrual bleeding and lower back pain and pressure on my bladder over this same time period, my Gynecologist shared that the most permanent and effective remedy for my issues was to have a hysterectomy.  I had the hysterectomy on 2/27/24. The treatment for Mast Cell Activation Syndrome consists of increased anti-histamines, a mast cell stabilizer, and a low-histamine diet, which I was prescribed and benefited to some degree from being on. I sought treatment for my lingering fatigue and cognition impairments after my hysterectomy, at a Wellness Center, where I received a variety of treatments including, hyperbaric oxygen therapy, IV therapy, hormone replacement therapy, treatment with steroids, low dose naltexrone, and a significant amount of supplements and nutritional support. Since this treatment program, I have returned to work and am performing normal duties with this elevated level of prescription and nutritional support. My fatigue is improved, although I tire more easily and require more sleep. My impaired cognition has also improved, but I still experience word-finding issues, brain-fog, lack of concentration, all worsened by energy exertion.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Fatigue, Lethargy, Pain in extremity, Pyrexia
Clinical narrative: Sore arm. Chills, and then a 101.9F fever overnight. Fever was gone the morning of July 3rd. I was very tired and lethargic for the rest of that day.